43
Growth Score
pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
456079
Wells Pharma is an FDA-registered 503B Outsourcing Facility, providing Ready-To-Use medications to hospitals and surgical centers.
- Tony Schwartz: Founder & President
- Theaquiata Mitchell: Senior Vice President of Quality
About the Company
Wells Pharma operates as an FDA-registered 503B Outsourcing Facility, offering Ready-To-Use (RTU) medications to hospitals and surgical centers. The company's primary focus is on healthcare, digital healthcare, and pharmaceutical compounding facilities. Wells Pharma provides a range of services including drug safety, with a dedicated contact
for reporting suspected adverse reactions. The company also offers a 'Team Spotlight' series, allowing customers to meet and interact with their team of experts. Wells Pharma's products include Atropine 0.4 mg/mL and Dextrose 500 mg/mL in SWFI, among others.
